Personal Information
Organization / Workplace
Greater San Diego Area United States
Occupation
Strategy and Business Development Executive. Management Consultant. Former Senior Equity Analyst (sell side).
Industry
Medical / Health Care / Pharmaceuticals
Website
wingibbons.wordpress.com
About
My background merges industry, consulting, and financial services, predominantly for innovative clinical diagnostic, life science, and therapeutic companies. These have been based on biotechnology, nanotechnology, and microfluidics, as well as novel biomarkers. This experience enables me to contribute highly as a senior leader or consultant.
Most recently, I was Senior Vice President for Corporate Development at Agena Bioscience, which makes genetic testing equipment. For the clinical diagnostic and life science fields, I have also been a senior leader at Roche, Merck, Biosite, Siloam Bioscience, and Nanosphere.
In financial services, I was the group head for healthcare equity research,...
Tags
diagnostics
ivd
diagnostic
in vitro diagnostics
in-vitro diagnostic
biomarkers
biomarker
product development
analytical modeling
market research
market assessment
forecasting
product pipelines
marketing strategy
product management
heart failure
focus group
rituxan
product portfolio
cardiovascular disorders
chf
drug portfolio
drug pipeline
troponin
bnp
acute coronary syndrome
new product development
marketing analysis
epistemology
companion diagnostics
personalized medicine
stroke
rheumatoid arthritis
business development
medical devices
strategic marketing
r&d
strategy
dna sequencing
next gen sequencing
biotechnology and pharmaceuticals
ngs
dna
bioinformatics
genomics
hiv
hepatitis
novartis
roche
hcv
hologic
gates foundation
blood donation
obamacare
disease management (health)
disease management
ccp
autoimmune
lupus
enbrel
diagnostic algorithms
discovery
validation
blood bank
tropical diseases
aabb
china
india
aids
chagas
blood screening
hmo
medical imaging
hospice
hospitals
biologicals
pharmaceuticals
health insurance portability and accountability ac
accountable care organization
aco
dental
physician offices
cro
labs
hcit
life science tools
patient
payor
kellogg
nanoarray
microarray
c. difficile
myocardial infarction
cardiotoxicity
prostate cancer
psa
connective tissue disease
allergen
allergy
nanotechnology
licensing
surveys
strategic planning
product screening
divest
spin off
spin out
cvc
corporate venture capital
quantitative research
public health
blood
nucleic acid test
point of care
gen-probe
gardasil
affordable care act
aca
hecon
health economics
pharmacoeconomics
patient protection and affordable care act
See more
Presentations
(15)Documents
(3)Personal Information
Organization / Workplace
Greater San Diego Area United States
Occupation
Strategy and Business Development Executive. Management Consultant. Former Senior Equity Analyst (sell side).
Industry
Medical / Health Care / Pharmaceuticals
Website
wingibbons.wordpress.com
About
My background merges industry, consulting, and financial services, predominantly for innovative clinical diagnostic, life science, and therapeutic companies. These have been based on biotechnology, nanotechnology, and microfluidics, as well as novel biomarkers. This experience enables me to contribute highly as a senior leader or consultant.
Most recently, I was Senior Vice President for Corporate Development at Agena Bioscience, which makes genetic testing equipment. For the clinical diagnostic and life science fields, I have also been a senior leader at Roche, Merck, Biosite, Siloam Bioscience, and Nanosphere.
In financial services, I was the group head for healthcare equity research,...
Tags
diagnostics
ivd
diagnostic
in vitro diagnostics
in-vitro diagnostic
biomarkers
biomarker
product development
analytical modeling
market research
market assessment
forecasting
product pipelines
marketing strategy
product management
heart failure
focus group
rituxan
product portfolio
cardiovascular disorders
chf
drug portfolio
drug pipeline
troponin
bnp
acute coronary syndrome
new product development
marketing analysis
epistemology
companion diagnostics
personalized medicine
stroke
rheumatoid arthritis
business development
medical devices
strategic marketing
r&d
strategy
dna sequencing
next gen sequencing
biotechnology and pharmaceuticals
ngs
dna
bioinformatics
genomics
hiv
hepatitis
novartis
roche
hcv
hologic
gates foundation
blood donation
obamacare
disease management (health)
disease management
ccp
autoimmune
lupus
enbrel
diagnostic algorithms
discovery
validation
blood bank
tropical diseases
aabb
china
india
aids
chagas
blood screening
hmo
medical imaging
hospice
hospitals
biologicals
pharmaceuticals
health insurance portability and accountability ac
accountable care organization
aco
dental
physician offices
cro
labs
hcit
life science tools
patient
payor
kellogg
nanoarray
microarray
c. difficile
myocardial infarction
cardiotoxicity
prostate cancer
psa
connective tissue disease
allergen
allergy
nanotechnology
licensing
surveys
strategic planning
product screening
divest
spin off
spin out
cvc
corporate venture capital
quantitative research
public health
blood
nucleic acid test
point of care
gen-probe
gardasil
affordable care act
aca
hecon
health economics
pharmacoeconomics
patient protection and affordable care act
See more